Finally, OS analysis observed that high expression of HNRNPA2B1 in nine cancers resulted in poor prognosis, including LGG, TARGET-LAML, LUAD, SARC, LIHC, LAML, ACC, KICH, GBMLGG, and low expression of HNRNPA2B1 in OV resulted in poor prognosis (Supplementary figure 1, Supplementary table 2). Here, HNRNPA2B1 is linked to cancer.